HADEN P
Can Med Assoc J. 1964 Oct 31;91(18):974-5.
The psychological effects of abrupt withdrawal of ataractic drugs have been studied by others. Physical symptoms also occur under such circumstances and include abdominal pain, nausea and vomiting. Forty patients were divided into four groups of 10, each group receiving one of the following drugs: chlorpromazine, thioridazine, perphenazine or chlorprothixene. This medication was then suddenly withdrawn. In each of the chlorpromazine and thioridazine groups, three patients had gastrointestinal symptoms within 48 hours, lasting one to eight days. One patient on chlorprothixene, 450 mg. daily, experienced symptoms for six days. Perphenazine withdrawal produced no such symptoms. Thioridazine has little antiemetic action but perphenazine is prescribed for vomiting; hence it seems unlikely that the reported symptoms are due to a rebound action on the vomiting centre.These findings are relevant to the situation of withdrawal of ataractics prior to administration of anesthetics and to drug studies involving cross-over from an active compound to a placebo. The increasing use of ataractics suggests that this additional diagnostic possibility should be considered in the presence of obscure gastrointestinal symptoms.
其他人已经研究了安定药突然停药的心理影响。在这种情况下也会出现身体症状,包括腹痛、恶心和呕吐。40名患者被分成4组,每组10人,每组服用以下药物之一:氯丙嗪、硫利达嗪、奋乃静或氯普噻吨。然后突然停药。在氯丙嗪组和硫利达嗪组中,各有3名患者在48小时内出现胃肠道症状,持续1至8天。一名每天服用450毫克氯普噻吨的患者出现症状达6天。停用奋乃静未出现此类症状。硫利达嗪几乎没有止吐作用,但奋乃静是用于治疗呕吐的;因此,报告的症状似乎不太可能是由于对呕吐中枢的反跳作用所致。这些发现与麻醉前停用安定药的情况以及涉及从活性化合物交叉到安慰剂的药物研究有关。安定药的使用日益增加,这表明在出现不明原因的胃肠道症状时应考虑这种额外的诊断可能性。